Use of IMiD3, a Thalidomide Analog, as an Adjunct to Therapy for Experimental Tuberculous Meningitis

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Antimicrob Agents Chemother
Prif Awduron: Tsenova, Liana, Mangaliso, Bande, Muller, George, Chen, Yong, Freedman, Victoria H., Stirling, David, Kaplan, Gilla
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Microbiology (ASM) 2002
Pynciau:
Experimental Therapeutics
Mynediad Ar-lein:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127267/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12019105/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.6.1887-1895.2002
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg